filmov
tv
Adjuvant Hormone Therapy: Is Ten Years Better Than Five presented by Kathleen Fielder, MD
Показать описание
Compass Oncology
Breast Cancer (Disease Or Medical Condition)
Oncology (Medical Specialty)
Рекомендации по теме
0:28:09
Adjuvant Hormone Therapy: Is Ten Years Better Than Five presented by Kathleen Fielder, MD
0:10:02
Breast Cancer: Extended Adjuvant Endocrine Therapy
0:04:54
Adjuvant Hormonal Therapy for Estrogen Receptor Positive Early Stage Breast Cancer - Mayo Clinic
1:41:26
Education Session: Trends in Adjuvant Endocrine Therapy
0:38:22
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit
0:22:14
Adjuvant endocrine therapy in postmenopausal women: Risk stratification, type & duration
0:06:44
Why Stop Hormonal Therapy After 10 Years for HR+ Breast Cancer?
0:06:09
Adjuvant endocrine therapy for breast cancer: optimal durations and regimens
0:30:56
Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures
0:01:50
Challenges With Patient Selection for Extended Adjuvant Endocrine Therapy in Breast Cancer
0:24:33
Session 9: Adjuvant endocrine therapy for premenopausal women: Risk stratification, type & durat...
0:07:50
Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women with hormone rec...
0:02:33
Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer
0:17:02
Paul E. Goss: Extended adjuvant endocrine therapy in hormone-receptor + BC
0:24:02
How to advance adjuvant hormonal therapy for BREAST CANCER? Improvement over Tamoxifen
0:12:30
Long term Morbidity Mortality of ADT and Radiation Therapy
0:06:48
How to use endocrine therapy in premenopausal women with ER+ early breast cancer
0:48:22
Adjuvant Endocrine Therapy for high-risk breast cancer
0:01:56
Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer
0:04:01
Duration of Endocrine Therapy in Breast Cancer
0:05:32
ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer
0:00:45
Is there a potential benefit of intermediate duration of adjuvant endocrine therapy?
0:22:48
Adjuvant Therapy of Breast Cancer
0:02:10
monarchE: adjuvant abemaciclib + endocrine therapy in patients with HR+, HER2- high-risk eBC